Notably, MDA-MB-231 cells displayed markedly decreased HDAC6 expression upon treatment, consistent with literature reports that TNBC exhibits elevated HDAC6 levels relative to other breast cancer subtypes. The gene discussed is HDAC6; the disease is breast carcinoma.